GSK2647544 是一种口服的、选择性的Lp-PLA2抑制剂。Lp-PLA2是一种钙非依赖性磷脂酶 A2，具有促炎活性，主要由单核细胞衍生的巨噬细胞分泌。

GSK2647544 is an orally available, selective inhibitor of Lp-PLA2. Lipoprotein-associated phospholipase (Lp-PLA2) is a calcium-independent phospholipase A2 with proinflammatory activities that is primarily secreted by monocyte-derived macrophages [1].

1380426-95-8

C24H18ClF3N4O3

502.87

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years